跳至主要内容
临床试验/IRCT2013102315045N2
IRCT2013102315045N2已完成2 期

Effect of glibenclamide in women with gestational diabetes on maternal and neonatal outcomes

Vice Chancellor for Research, Kashan University of Medical Sciences and Health Service0 个研究点目标入组 278 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
278

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • female age between 18 to 45 years; singleton pregnancy; no history of diabetes before pregnancy; gestational age between 11-33 weeks
  • Exclusion criteria: premature rupture of membrane; severe infectious diseases;
  • cardiovascular diseases; acute respiratory failure; hematological disease; renal disease; liver disease

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Kashan University of Medical Sciences and Health Service

相似试验